| Title: |
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study |
| Authors: |
Jackson, C; Stewart, ID; Plekhanova, T; Cunningham, PS; Hazel, AL; Al-Sheklly, B; Aul, R; Bolton, CE; Chalder, T; Chalmers, JD; Chaudhuri, N; Docherty, AB; Donaldson, G; Edwardson, CL; Elneima, O; Greening, NJ; Hanley, NA; Harris, VC; Harrison, EM; Ho, L-P; Houchen-Wolloff, L; Howard, LS; Jolley, CJ; Jones, MG; Leavy, OC; Lewis, KE; Lone, NI; Marks, M; McAuley, HJC; McNarry, MA; Patel, BV; Piper-Hanley, K; Poinasamy, K; Raman, B; Richardson, M; Rivera-Ortega, P; Rowland-Jones, SL; Rowlands, AV; Saunders, RM; Scott, JT; Sereno, M; Shah, AM; Shikotra, A; Singapuri, A; Stanel, SC; Thorpe, M; Wootton, DG; Yates, T; Gisli Jenkins, R; Singh, SJ |
| Contributors: |
Group, PHOSP-COVID Study Collaborative |
| Publisher Information: |
Elsevier |
| Publication Year: |
2023 |
| Collection: |
Oxford University Research Archive (ORA) |
| Description: |
Background Sleep disturbance is common following hospital admission both for COVID-19 and other causes. The clinical associations of this for recovery after hospital admission are poorly understood despite sleep disturbance contributing to morbidity in other scenarios. We aimed to investigate the prevalence and nature of sleep disturbance after discharge following hospital admission for COVID-19 and to assess whether this was associated with dyspnoea. Methods CircCOVID was a prospective multicentre cohort substudy designed to investigate the effects of circadian disruption and sleep disturbance on recovery after COVID-19 in a cohort of participants aged 18 years or older, admitted to hospital for COVID-19 in the UK, and discharged between March, 2020, and October, 2021. Participants were recruited from the Post-hospitalisation COVID-19 study (PHOSP-COVID). Follow-up data were collected at two timepoints: an early time point 2–7 months after hospital discharge and a later time point 10–14 months after hospital discharge. Sleep quality was assessed subjectively using the Pittsburgh Sleep Quality Index questionnaire and a numerical rating scale. Sleep quality was also assessed with an accelerometer worn on the wrist (actigraphy) for 14 days. Participants were also clinically phenotyped, including assessment of symptoms (ie, anxiety [Generalised Anxiety Disorder 7-item scale questionnaire], muscle function [SARC-F questionnaire], dyspnoea [Dyspnoea-12 questionnaire] and measurement of lung function), at the early timepoint after discharge. Actigraphy results were also compared to a matched UK Biobank cohort (non-hospitalised individuals and recently hospitalised individuals). Multivariable linear regression was used to define associations of sleep disturbance with the primary outcome of breathlessness and the other clinical symptoms. PHOSP-COVID is registered on the ISRCTN Registry (ISRCTN10980107). Findings 2320 of 2468 participants in the PHOSP-COVID study attended an early timepoint research visit a median of 5 ... |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/s2213-2600(23)00124-8 |
| Availability: |
https://doi.org/10.1016/s2213-2600(23)00124-8; https://ora.ox.ac.uk/objects/uuid:09c3cb51-0902-4931-b3db-938f1ea3cd25 |
| Rights: |
info:eu-repo/semantics/openAccess ; CC Attribution (CC BY) |
| Accession Number: |
edsbas.285C4402 |
| Database: |
BASE |